Skip to main content
Article
Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees
Journal of Oncology Pharmacy Practice (2019)
  • Krish Patel, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, USA
  • Vinjamuri S Sudhir, ZS Associates
  • Shaum Kabadi, AstraZeneca
  • Joanna C Huang, ZS Associates
  • Sanchita Porwal, ZS Associates
  • Kushan Thakkar, ZS Associates
  • John M Pagel, Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, USA
Publication Date
February 5, 2019
DOI
10.1177/1078155219827637
Citation Information
Krish Patel, Vinjamuri S Sudhir, Shaum Kabadi, Joanna C Huang, et al.. "Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees" Journal of Oncology Pharmacy Practice (2019)
Available at: http://works.bepress.com/john-pagel/291/